Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1930 2
1934 1
1935 3
1936 1
1938 1
1941 1
1942 1
1945 7
1946 19
1947 26
1948 32
1949 31
1950 57
1951 51
1952 53
1953 61
1954 67
1955 69
1956 71
1957 58
1958 54
1959 69
1960 97
1961 101
1962 106
1963 148
1964 211
1965 192
1966 184
1967 189
1968 271
1969 260
1970 269
1971 272
1972 301
1973 224
1974 277
1975 267
1976 277
1977 262
1978 240
1979 253
1980 253
1981 305
1982 337
1983 312
1984 347
1985 392
1986 410
1987 375
1988 408
1989 495
1990 451
1991 497
1992 479
1993 505
1994 461
1995 484
1996 486
1997 478
1998 515
1999 531
2000 601
2001 571
2002 611
2003 643
2004 644
2005 683
2006 781
2007 700
2008 781
2009 814
2010 861
2011 980
2012 1043
2013 1085
2014 1128
2015 1188
2016 1344
2017 1453
2018 1432
2019 1698
2020 2027
2021 2128
2022 2369
2023 2035
2024 747

Text availability

Article attribute

Article type

Publication date

Search Results

38,757 results

Results by year

Filters applied: . Clear all
Page 1
When to Suspect a Diagnosis of Amyloidosis.
Vaxman I, Gertz M. Vaxman I, et al. Acta Haematol. 2020;143(4):304-311. doi: 10.1159/000506617. Epub 2020 Apr 27. Acta Haematol. 2020. PMID: 32340017 Free article. Review.
Despite the etiological heterogeneity of systemic amyloidosis, the clinical manifestations of the different forms of amyloidosis largely overlap and depend upon the effected organ. ...Cardiac amyloidosis is the major determinant of survival, and the earlier i …
Despite the etiological heterogeneity of systemic amyloidosis, the clinical manifestations of the different forms of amyloidosis …
Systemic amyloidosis.
Wechalekar AD, Gillmore JD, Hawkins PN. Wechalekar AD, et al. Lancet. 2016 Jun 25;387(10038):2641-2654. doi: 10.1016/S0140-6736(15)01274-X. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719234 Review.
Systemic light chain (AL) amyloidosis is the most common of these conditions, but wild-type transthyretin cardiac amyloidosis (ATTRwt) is increasingly being diagnosed. ...Survival in AL amyloidosis has improved markedly as novel chemotherapy agents have becom …
Systemic light chain (AL) amyloidosis is the most common of these conditions, but wild-type transthyretin cardiac amyloidosis …
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.
Falk RH, Alexander KM, Liao R, Dorbala S. Falk RH, et al. J Am Coll Cardiol. 2016 Sep 20;68(12):1323-41. doi: 10.1016/j.jacc.2016.06.053. J Am Coll Cardiol. 2016. PMID: 27634125 Free article. Review.
The amyloidoses are a group of protein-folding disorders in which 1 organ is infiltrated by proteinaceous deposits known as amyloid. ...The last decade has seen considerable progress in understanding the amyloidoses. In this review, current and novel approaches to t …
The amyloidoses are a group of protein-folding disorders in which 1 organ is infiltrated by proteinaceous deposits known as amyloid. …
Amyloidosis: a clinical overview.
Hazenberg BP. Hazenberg BP. Rheum Dis Clin North Am. 2013 May;39(2):323-45. doi: 10.1016/j.rdc.2013.02.012. Epub 2013 Mar 13. Rheum Dis Clin North Am. 2013. PMID: 23597967 Review.
The classification of amyloidosis is based on the chemical characterization of the precursor protein. Deposition of amyloid is localized or systemic. The 4 main types of systemic amyloidosis are AL, AA, ATTR, and Abeta2M type. A schematic approach is proposed for th …
The classification of amyloidosis is based on the chemical characterization of the precursor protein. Deposition of amyloid is locali …
How I treat AL amyloidosis.
Palladini G, Merlini G. Palladini G, et al. Blood. 2022 May 12;139(19):2918-2930. doi: 10.1182/blood.2020008737. Blood. 2022. PMID: 34517412 Free article.
The treatment of patients with systemic light chain (AL) amyloidosis is a challenge to hematologists. Despite its generally small size, the underlying clone causes a rapidly progressing, often devastating multiorgan dysfunction through the toxic light chains that form amyl …
The treatment of patients with systemic light chain (AL) amyloidosis is a challenge to hematologists. Despite its generally small siz …
Confirming the Diagnosis of Amyloidosis.
Wisniowski B, Wechalekar A. Wisniowski B, et al. Acta Haematol. 2020;143(4):312-321. doi: 10.1159/000508022. Epub 2020 Jun 16. Acta Haematol. 2020. PMID: 32544917 Free article. Review.
The identity of the precursor protein often predicts the disease phenotype, although many of the amyloidoses have overlapping clinical features. Most patients with amyloidosis will require biopsy of an involved organ or tissue to confirm the diagnosis. ...Here we su …
The identity of the precursor protein often predicts the disease phenotype, although many of the amyloidoses have overlapping clinica …
AL amyloidosis: advances in diagnostics and treatment.
Ryšavá R. Ryšavá R. Nephrol Dial Transplant. 2019 Sep 1;34(9):1460-1466. doi: 10.1093/ndt/gfy291. Nephrol Dial Transplant. 2019. PMID: 30299492 Review.
AL amyloidosis ultimately leads to destruction of tissues and progressive disease. With recent advances in the treatment, the importance of an early diagnosis of amyloidosis and correct assessment of its type is high. Histologic confirmation is based on Congo red de …
AL amyloidosis ultimately leads to destruction of tissues and progressive disease. With recent advances in the treatment, the importa …
The Pathology of Amyloidosis in Classification: A Review.
Picken MM. Picken MM. Acta Haematol. 2020;143(4):322-334. doi: 10.1159/000506696. Epub 2020 May 11. Acta Haematol. 2020. PMID: 32392555 Free article. Review.
SUMMARY: in clinical practice, it is critical to distinguish between treatable versus non-treatable amyloidoses. Moreover, amyloidoses with a genetic component must be distinguished from the sporadic types and systemic amyloidoses must be distinguished from t …
SUMMARY: in clinical practice, it is critical to distinguish between treatable versus non-treatable amyloidoses. Moreover, amyloid …
Renal amyloidosis: a new time for a complete diagnosis.
Feitosa VA, Neves PDMM, Jorge LB, Noronha IL, Onuchic LF. Feitosa VA, et al. Braz J Med Biol Res. 2022 Oct 3;55:e12284. doi: 10.1590/1414-431X2022e12284. eCollection 2022. Braz J Med Biol Res. 2022. PMID: 36197414 Free PMC article. Review.
The kidney is the organ most frequently involved in systemic amyloidosis. Renal amyloidosis is characterized by acellular pathologic Congo red-positive deposition of amyloid fibrils in glomeruli, vessels, and/or interstitium. ...Of note, laser microdissection/mass s …
The kidney is the organ most frequently involved in systemic amyloidosis. Renal amyloidosis is characterized by acellular path …
Amyloidosis of the Lung.
Khoor A, Colby TV. Khoor A, et al. Arch Pathol Lab Med. 2017 Feb;141(2):247-254. doi: 10.5858/arpa.2016-0102-RA. Arch Pathol Lab Med. 2017. PMID: 28134587 Free article. Review.
Three different clinicopathologic forms of amyloidosis can be seen in the lungs: diffuse alveolar-septal amyloidosis, nodular pulmonary amyloidosis, and tracheobronchial amyloidosis. ...DATA SOURCES: -This is a narrative review based on PubMed searches …
Three different clinicopathologic forms of amyloidosis can be seen in the lungs: diffuse alveolar-septal amyloidosis, nodular …
38,757 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "amyloidosis"